CLINICAL_TRIALS
trial_result
· 2010-10-20
Clinical Trial Update: V710 First-In-Man (FIM) Study (V710-001) [Phase 1]
Summary
Merck's V710 first-in-man Phase 1 study for preventing Staphylococcus aureus infections has completed, with results posted in October 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Staphylococcal Infections | Phase 1 | Status: COMPLETED | Results posted: 2010-10-20